Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru.
暂无分享,去创建一个
J. Musser | H. Soini | Xi Pan | P. Escalante | S. Ramaswamy | J M Musser | X. Pan | X Pan | S Ramaswamy | H Soini | P Escalante | H Sanabria | O Valiente-Castillo | H. Sanabria | O. Valiente-Castillo | Hanna Soini | James M. Musser | Patricio Escalante | L. Asencio
[1] J. T. Crawford,et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. , 1996, JAMA.
[2] J. T. Crawford,et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology , 1993, Journal of clinical microbiology.
[3] D van Soolingen,et al. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. , 1996, The Journal of infectious diseases.
[4] M. Raviglione,et al. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] C. Woodley,et al. Transmission of a highly drug-resistant strain (strain W1) of Mycobacterium tuberculosis. Community outbreak and nosocomial transmission via a contaminated bronchoscope. , 1997, JAMA.
[6] J. Musser,et al. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms , 1997, Antimicrobial agents and chemotherapy.
[7] D. van Soolingen,et al. Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. , 1995, The Journal of infectious diseases.
[8] A. Telenti,et al. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations , 1997, Antimicrobial agents and chemotherapy.
[9] V. Ritacco,et al. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. , 1997, The Journal of infectious diseases.
[10] F. Baquero,et al. Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients , 1997 .
[11] C. Inderlied,et al. Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay. , 1997, The Journal of infectious diseases.
[12] P. Small,et al. The transcontinental transmission of tuberculosis: A molecular epidemiological assessment. , 1996, American journal of public health.
[13] A. Telenti,et al. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level , 1997, Journal of clinical microbiology.
[14] L. Wayne,et al. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. , 1974, The American review of respiratory disease.
[15] Ying Zhang,et al. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus , 1996, Nature Medicine.
[16] P. de Rijk,et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin , 1997, Antimicrobial agents and chemotherapy.
[17] J T Douglas,et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia , 1995, Journal of clinical microbiology.
[18] A. Telenti,et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations , 1994, Antimicrobial Agents and Chemotherapy.
[19] A. Telenti,et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis , 1993, The Lancet.
[20] J. Musser,et al. Antimicrobial agent resistance in mycobacteria: molecular genetic insights , 1995, Clinical microbiology reviews.
[21] J. Musser,et al. Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[22] I. H. Lim,et al. Lack of clinical significance for the common arginine-to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore. , 1997, The Journal of infectious diseases.
[23] T. Whittam,et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] L. Benson,et al. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. , 1997, The Journal of infectious diseases.
[25] Y. Kazumi,et al. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[26] D. Young,et al. Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism , 1997, Journal of clinical microbiology.
[27] J. Musser,et al. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[28] M. Felten,et al. Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[29] F. Portaels,et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[30] K. Feldmann,et al. Disequilibria in the distribution of rpoB alleles in rifampicin-resistant M. tuberculosis isolates from Germany and Sierra Leone. , 1997, Microbial drug resistance.
[31] A. Telenti,et al. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. , 1995, Archives of pathology & laboratory medicine.
[32] P. Groenen,et al. Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method , 1993, Molecular microbiology.
[33] J. Musser,et al. Routine rapid Mycobacterium species assignment based on species-specific allelic variation in the 65-kilodalton heat shock protein gene (hsp65). , 1997, Archives of pathology & laboratory medicine.
[34] A. Telenti,et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol , 1997, Nature Medicine.
[35] A. Khomenko,et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. , 1969, Bulletin of the World Health Organization.
[36] J. T. Crawford,et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. , 1992, The New England journal of medicine.
[37] J. Bates,et al. Diversity of DNA Fingerprints ofMycobacterium tuberculosis Isolates in the United States , 1998, Journal of Clinical Microbiology.
[38] R. Gilman,et al. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis , 1997, Antimicrobial agents and chemotherapy.
[39] H L Rieder,et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 1998, The New England journal of medicine.
[40] J. T. Crawford,et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. , 1996, JAMA.